NeurAxis (NASDAQ:NRXS) & Precision Optics (NASDAQ:POCI) Head-To-Head Contrast

Insider and Institutional Ownership

13.7% of Precision Optics shares are owned by institutional investors. Comparatively, 11.8% of NeurAxis shares are owned by institutional investors. 16.3% of Precision Optics shares are owned by insiders. Comparatively, 15.2% of NeurAxis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares Precision Optics and NeurAxis”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precision Optics	$18.98 million	1.61	-$2.95 million	($0.62)	-7.74
NeurAxis	$2.46 million	7.08	-$14.63 million	($1.84)	-1.35

Precision Optics has higher revenue and earnings than NeurAxis. Precision Optics is trading at a lower price-to-earnings ratio than NeurAxis, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Precision Optics and NeurAxis’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Precision Optics	-20.01%	-35.51%	-21.67%
NeurAxis	-492.76%	N/A	-641.25%

Volatility and Risk

Precision Optics has a beta of 0.27, suggesting that its share price is 73% less volatile than the S&P 500. Comparatively, NeurAxis has a beta of 4.2, suggesting that its share price is 320% more volatile than the S&P 500.

Summary

Precision Optics beats NeurAxis on 7 of the 11 factors compared between the two stocks.

About Precision Optics

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

About NeurAxis

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.